Brief: Grand Pharmaceutical Says New MRA Drug Eplerenone Tablets Granted Drug Registration Certificate
03/08/2023 11:40
Aug 3 (Reuters) - Grand Pharmaceutical Group Ltd
0512.HK :
* NEW MRA DRUG OF GROUP EPLERENONE TABLETS GRANTED DRUG
REGISTRATION CERTIFICATE
* EPLERENONE TABLETS GRANTED DRUG REGISTRATION CERTIFICATE
BY NMPA
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement